Criteria used for the main assessment of response type
| Type . | Marrow . | Counts . | Clinical . | Transfusions . |
|---|---|---|---|---|
| CR | Blasts <5% | ANC >1 × 109/L and PLT >100 × 109/L | and Absence of circulating blasts; absence of extramedullary disease | and No transfusions in the prior 7 d |
| CRh | Blasts <5% | ANC >0.5 × 109/L and PLT >50 × 109/L, but not fulfilling count recovery for CR | and Absence of circulating blasts; absence of extramedullary disease | and No transfusions in the prior 7 d |
| CRL | Blasts <5% | and ANC ≤0.5 × 109/L and PLT ≤50 × 109/L | and Absence of circulating blasts; absence of extramedullary disease | or Any transfusions in the prior 7 d |
| NR | Blasts ≥5% | NA | or Circulating blasts or extramedullary disease | NA |
| Type . | Marrow . | Counts . | Clinical . | Transfusions . |
|---|---|---|---|---|
| CR | Blasts <5% | ANC >1 × 109/L and PLT >100 × 109/L | and Absence of circulating blasts; absence of extramedullary disease | and No transfusions in the prior 7 d |
| CRh | Blasts <5% | ANC >0.5 × 109/L and PLT >50 × 109/L, but not fulfilling count recovery for CR | and Absence of circulating blasts; absence of extramedullary disease | and No transfusions in the prior 7 d |
| CRL | Blasts <5% | and ANC ≤0.5 × 109/L and PLT ≤50 × 109/L | and Absence of circulating blasts; absence of extramedullary disease | or Any transfusions in the prior 7 d |
| NR | Blasts ≥5% | NA | or Circulating blasts or extramedullary disease | NA |
ANC, absolute neutrophil count; NA, not applicable; PLT, platelet count.